Apatinib for recurrent/progressive glioblastoma multiforme: A salvage option

Purpose: The recurrent/progressive glioblastoma multiforme (GBM) carries a dismal prognosis and the definitive treatment strategy has not yet been established. This study aimed to assess the efficacy and safety of apatinib in recurrent/progressive GBM patients. Materials and methods: The clinical da...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Hong-Hong, Du, Xiao-Jing, Deng, Mei-Ling, Zheng, Lie, Yao, Dun-Chen, Wang, Zhi-Qiang, Yang, Qun-Ying, Wu, Shao-Xiong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9432461/
https://www.ncbi.nlm.nih.gov/pubmed/36060005
http://dx.doi.org/10.3389/fphar.2022.969565

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9432461/
https://www.ncbi.nlm.nih.gov/pubmed/36060005
http://dx.doi.org/10.3389/fphar.2022.969565

Ejemplares similares